The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Author: De HertM, DetrauxJ, PaniL, PeuskensJ

Paper Details 
Original Abstract of the Article :
Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia (HPRL) as a common adverse effect of antipsychotic medication, which remains the cornerstone of pharmacological treatment for patients with schizophrenia. Although treatment with second-generation antipsychoti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022988/

データ提供:米国国立医学図書館(NLM)

The Impact of Antipsychotics on Serum Prolactin Levels

This research provides a comprehensive review of the effects of various antipsychotics on serum prolactin levels. It highlights the common adverse effect of hyperprolactinemia associated with antipsychotic medication, particularly with first-generation antipsychotics. The authors discuss the detailed effects of both second-generation and newly approved antipsychotics on prolactin levels, focusing on the incidence of hyperprolactinemia. They emphasize the need for further research to understand the mechanisms underlying these effects and optimize treatment strategies.

Antipsychotics and Prolactin: Navigating a Delicate Balance

This research delves into the complex relationship between antipsychotics and prolactin levels. The authors provide a detailed analysis of the effects of various antipsychotic medications on serum prolactin levels, highlighting the potential for hyperprolactinemia, especially with first-generation medications. They emphasize the need for careful monitoring and management of prolactin levels in patients receiving these treatments.

The Sands of Psychiatric Treatment: A Journey of Understanding

The field of psychiatric treatment is like a vast and ever-changing desert, filled with complexities and unknowns. This research, like a seasoned guide, explores the intricate interplay between antipsychotics and prolactin levels. The authors delve into the potential for hyperprolactinemia, a condition that can have significant implications for patient health. Their review offers valuable insights into the challenges and opportunities of managing prolactin levels in patients receiving antipsychotics.

Dr. Camel's Conclusion

This study underscores the importance of careful monitoring and management of prolactin levels in patients receiving antipsychotic medications. It highlights the need for further research to optimize treatment strategies and minimize the potential for adverse effects associated with these medications.

Date :
  1. Date Completed 2015-01-13
  2. Date Revised 2023-09-19
Further Info :

Pubmed ID

24677189

DOI: Digital Object Identifier

PMC4022988

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.